Taurine chloramine - Its role in immunity and new perspectives for clinical use

Central-European Journal of Immunology

Volumn 27, Issue 2, 2002, Pages 69-74

  Koprowski, Marek ^a   Marcinkiewicz, Janusz ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Immunity; Taurine chloramine

Indexed keywords

ANTIBIOTIC AGENT; CYSTEINE; HYPOCHLOROUS ACID; METHIONINE; STEROID; TAURINE CHLORAMINE; TAURINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTIVIRAL ACTIVITY; ATHEROSCLEROSIS; CONTROLLED STUDY; CYTOTOXICITY; EYE DISEASE; FUNGICIDAL ACTIVITY; IMMUNITY; IMMUNOMODULATION; INFECTION; INFLAMMATORY DISEASE; MOUSE; NEUTROPHIL; NONHUMAN; OXIDATION; REVIEW; RHEUMATOID ARTHRITIS; SKIN DISEASE; SYNTHESIS;

EID: 11044224141     PISSN: 14263912     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Weiss SJ, Klein R, Slivka A, Wei M (1982): Chlorination of taurine by human neutrophils. Evidence for hypochlorous acid generation. J Clin Invest 70: 598-607.
2. Grisham MB, Jefferson MM, Melton DF, Thomas EL (1984): Chlorination of endogenous amines by isolated neutrophils. Ammonia - dependent bactericidal, cytotoxic, and cytolytic activities of the chloramines. J Biol Chem 259: 10404-10413.
3. Thomas EL, Grisham MB, Jefferson MM (1986): Preparation and characterization of chloramines. Methods Enzymol 132: 569-585.
4. Thomas EL, Grisham MB, Jefferson MM (1983): Myeloperoxidase-dependent effect of amines on functions of isolated neutrophils. J Clin Invest 72: 441-454.
5. McLoughlin DM, Stapleton PP, Bloomfield FJ (1991): Influence of taurine and a substituted taurine on the respiratory burst pathway in the inflammatory response. Biochem Soc Trans 19: 73-78.
6. Banks MA, Porter DW, Martin WG, Castranova V (1992): Taurine protects against oxidant injury to rat alveolar pneumocytes. Adv Exp Med Biol 315: 341-354.
7. Davies JM, Horwitz DA, Davies KJ (1993): Potential roles of hypochlorous acid and N-chloroamines in collagen breakdown by phagocytic cells in synovitis. Free Radic Biol Med 15: 637-643.
8. Aruoma OI, Halliwell B, Hoey BM, Butler J (1988): The antioxidant action of taurine, hypotaurine and their metabolic precursors. Biochem J 256: 251-255.
9. Learn DB, Fried VA, Thomas EL (1990): Taurine and hypotaurine content of human leukocytes. J Leukoc Biol 48: 174-182.
10. Wright CE, Tallan HH, Lin YY, Gaull GE (1986): Taurine: biological update. Annu Rev Biochem 55: 427-453.
11. Marquez LA, Dunford HB (1994): Chlorination of taurine by myeloperoxidase. Kinetic evidence for an enzyme-bound intermediate. J Biol Chem 269: 7950-7956.
12. Weiss SJ, Lampert MB, Test ST (1983): Long-lived oxidants generated by human neutrophils: characterization and bioactivity. Science 222: 625-628.
13. Thomas EL, Grisham MB, Melton DF, Jefferson MM (1985): Evidence for a role of taurine in the in vitro oxidative toxicity of neutrophils toward erythrocytes. J Biol Chem 260: 3321-3329.
14. Cunningham C, Tipton KF, Dixon HB (1998): Conversion of taurine into N-chlorotaurine (taurine chloramine) and sulphoacetaldehyde in response to oxidative stress. Biochem J 330 (Pt 2): 939-945.
15. Klebanoff SJ, Hamon CB (1972): Role of myeloperoxidase-mediated antimicrobial systems in intact leukocytes. J Reticuloendothel Soc 12: 170-196.
16. Zgliczynski JM, Stelmaszynska T (1975): Chlorinating ability of human phagocytosing leucocytes. Eur J Biochem 56: 157-162.
17. Thomas EL (1979): Myeloperoxidase-hydrogen peroxidechloride antimicrobial system: effect of exogenous amines on antibacterial action against Escherichia coli. Infect Immun 25: 110-116.
18. Olszowska E, Olszowski S, Zgliczynski JM, Stelmaszynska T (1989): Enhancement of proteinase-mediated degradation of proteins modified by chlorination. Int J Biochem 21: 799-805.
19. Marcinkiewicz J, Chain BM, Olszowska E, Olszowski S, Zgliczynski JM (1991): Enhancement of immunogenic properties of ovalbumin as a result of its chlorination. Int J Biochem 23: 1393-1395.
20. Marcinkiewicz J, Olszowska E, Olszowski S, Zgliczynski JM (1992): Enhancement of trinitrophenyl-specific humoral response to TNP proteins as the result of carrier chlorination. Immunology 76: 385-388.
21. Claesson R, Karlsson M, Zhang Y, Carlsson J (1996): Relative role of chloramines, hypochlorous acid, and proteases in the activation of human polymorphonuclear leukocyte collagenase. J Leukoc Biol 60: 598-602.
22. Park E, Quinn MR, Wright CE, Schuller-Levis G (1993): Taurine chloramine inhibits the synthesis of nitric oxide and the release of tumor necrosis factor in activated RAW 264.7 cells. J Leukoc Biol 54: 119-124.
23. Park E, Schuller-Levis G, Quinn MR (1995): Taurine chloramine inhibits production of nitric oxide and TNF-alpha in activated RAW 264.7 cells by mechanisms that involve transcriptional and translational events. J Immunol 154: 4778-4784.
24. Kim C, Park E, Quinn MR, Schuller-Levis G (1996): The production of superoxide anion and nitric oxide by cultured murine leukocytes and the accumulation of TNF-alpha in the conditioned media is inhibited by taurine chloramine. Immunopharmacology 34: 89-95.
25. Marcinkiewicz J, Grabowska A, Bereta J, Stelmaszynska T (1995): Taurine chloramine, a product of activated neutrophils, inhibits in vitro the generation of nitric oxide and other macrophage inflammatory mediators. J Leukoc Biol 58:667-674.
26. Marcinkiewicz J, Grabowska A, Bereta J, Bryniarski K, Nowak B (1998): Taurine chloramine down-regulates the generation of murine neutrophil inflammatory mediators. Immunopharmacology 40: 27-38.
27. Marcinkiewicz J (1997): Neutrophil chloramines: missing links between innate and acquired immunity. Immunol Today 18: 577-580.
28. Kontny E, Grabowska A, Kowalczewski J, Kurowska M, Janicka I, Marcinkiewicz J, Maslinski W (1999): Taurine chloramine inhibition of cell proliferation and cytokine production by rheumatoid arthritis fibroblast-like synoviocytes. Arthritis Rheum 42: 2552-2560.
29. Marcinkiewicz J, Grabowska A, Chain BM (1998): Modulation of antigen-specific T-cell activation in vitro by taurine chloramine. Immunology 94: 325-330.
30. Marcinkiewicz J, Nowak B, Grabowska A, Bobek M, Petrovska L, Chain B (1999): Regulation of murine dendritic cell functions in vitro by taurine chloramine, a major product of the neutrophil myeloperoxidase-halide system. Immunology 98: 371-378.
31. Quinn MR, Park E, Schuller-Levis G (1996): Taurine chloramine inhibits prostaglandin E2 production in activated RAW 264.7 cells by post-transcriptional effects on inducible cyclooxygenase expression. Immunol Lett 50: 185-188.
32. Kontny E, Szczepanska K, Kowalczewski J, Kurowska M, Janicka I, Marcinkiewicz J, Maslinski W (2000): The mechanism of taurine chloramine inhibition of cytokine (interleukin-6, interleukin-8) production by rheumatoid arthritis fibroblast-like synoviocytes. Arthritis Rheum 43: 2169-2177.
33. Barua M, Liu Y, Quinn MR (2001): Taurine chloramine inhibits inducible nitric oxide synthase and tnf- alpha gene expression in activated alveolar macrophages: decreased nf- kappab activation and ikappab kinase activity. J Immunol 167: 2275-2281.
34. Nagl M, Larcher C, Gottardi W (1998): Activity of N-chlorotaurine against herpes simplex- and adenoviruses. Antiviral Res 38: 25-30.
35. Nagl M, Lass-Florl C, Neher A, Gunkel A, Gottardi W (2001): Enhanced fungicidal activity of N-chlorotaurine in nasal secretion. J Antimicrob Chemother 47: 871-874.
36. Wagner DK, Collins-Lech C, Sohnle PG (1986): Inhibition of neutrophil killing of Candida albicans pseudohyphae by substances which quench hypochlorous acid and chloramines. Infect Immun 51: 731-735.
37. Yazdanbakhsh M, Eckmann CM, Roos D (1987): Killing of schistosomula by taurine chloramine and taurine bromamine. Am J Trop Med Hyg 37: 106-110.
38. Nagl M, Hess MW, Pfaller K, Hengster P, Gottardi W (2000): Bactericidal activity of micromolar N-chlorotaurine: evidence for its antimicrobial function in the human defense system. Antimicrob Agents Chemother 44: 2507-2513.
39. Nagl M, Gottardi W (1998): Rapid killing of Mycobacterium terrae by N-chlorotaurine in the presence of ammonium is caused by the reaction product monochloramine. J Pharm Pharmacol 50: 1317-1320.
40. Nagl M, Hengster P, Semenitz E, Gottardi W (1999): The postantibiotic effect of N-chlorotaurine on Staphylococcus aureus. Application in the mouse peritonitis model. J Antimicrob Chemother 43: 805-809.
41. Nagl M, Pfausler B, Schmutzhard E, Fille M, Gottardi W (1998): Tolerance and bactericidal action of N-chlorotaurine in a urinary tract infection by an omniresistant Pseudomonas aeruginosa. Zentralbl Bakteriol 288: 217-223.
42. Nagl M, Teuchner B, Pottinger E, Ulmer H, Gottardi W (2000): Tolerance of N-chlorotaurine, a new antimicrobial agent, in infectious conjunctivitis - a phase II pilot study. Ophthalmologica 214: 111-114.
43. Benov L, Fridovich I (1996): Escherichia coli exhibits negative chemotaxis in gradients of hydrogen peroxide, hypochlorite, and N-chlorotaurine: products of the respiratory burst of phagocytic cells. Proc Natl Acad Sci U.S.A 93: 4999-5002.
44. Nagl M, Miller B, Daxecker F, Ulmer H, Gottardi W (1998): Tolerance of N-chlorotaurine, an endogenous antimicrobial agent, in the rabbit and human eye - a phase I clinical study. J Ocul Pharmacol Ther 14: 283-290.
45. Kwasny-Krochin B, Bobek M, Kontny E, Gluszko P, Biedron R, Chain BM, Maslinski W, Marcinkiewicz J (2002): Effect of taurine chloramine, the product of activated neutrophils, on the development of collagen-induced arthritis in DBA 1/J mice. Amino Acids 23: 419-426.
46. Hazell LJ, Arnold L, Flowers D, Waeg G, Malle E, Stocker R (1996): Presence of hypochlorite-modified proteins in human atherosclerotic lesions. J Clin Invest 97: 1535-1544.
47. Brennan ML, Anderson MM, Shih DM, Qu XD, Wang X, Mehta AC, Lim LL, Shi W, Hazen SL, Jacob JS, Crowley JR, Heinecke JW, Lusis AJ (2001): Increased atherosclerosis in myeloperoxidase-deficient mice. J Clin Invest 107: 419-430.